O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation

Developmental Biology

Volumn 346, Issue 1, 2010, Pages 25-38

  Du, Jianguang ^a   Takeuchi, Hideyuki ^a   Leonhard Melief, Christina ^a   Shroyer, Kenneth R ^a   Dlugosz, Malgosia ^a   Haltiwanger, Robert S ^a   Holdener, Bernadette C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Epithelial to mesenchymal transition; Extracellular matrix; Gastrulation; O fucose; Protein O fucosyltransferase; Thrombospondin type I repeat

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CELL PROTEIN; FIBROBLAST GROWTH FACTOR 8; FUCOSE; FUCOSYLTRANSFERASE; GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 3BETA; O FUCOSE; O FUCOSYLTRANSFERASE 2; PROTEIN CER1; PROTEIN NODAL; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; WNT3 PROTEIN; DRAP1 PROTEIN, MOUSE; REPRESSOR PROTEIN; SCLEROPROTEIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; TSRC1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOTION; CONTROLLED STUDY; ECTODERM; EMBRYO; ENDODERM; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FUCOSYLATION; GASTRULATION; GERM LAYER; HUMAN; HUMAN CELL; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TERATOMA; VASCULAR ENDOTHELIUM; ANIMAL; CYTOLOGY; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; MALE; METABOLISM; PHYSIOLOGY; PREGNANCY;

ANIMALS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FUCOSE; FUCOSYLTRANSFERASES; GASTRULATION; GERM LAYERS; HUMANS; MALE; MESODERM; MICE; PREGNANCY; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; THROMBOSPONDINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956161127     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2010.07.008     Document Type: Article

References (95)

1. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 2002, 4:599-604.
2. Adams J.C., Tucker R.P. The thrombospondin type 1 repeat (TSR) superfamily: diverse proteins with related roles in neuronal development. Dev. Dyn. 2000, 218:280-299.
3. Arnold S.J., Robertson E.J. Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo. Nat. Rev. Mol. Cell Biol. 2009, 10:91-103.
4. Belaoussoff M., Farrington S.M., Baron M.H. Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo. Development 1998, 125:5009-5018.
5. Ben-Haim N., Lu C., Guzman-Ayala M., Pescatore L., Mesnard D., et al. The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4. Dev. Cell 2006, 11:313-323.
6. Bornstein P., Agah A., Kyriakides T.R. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 2004, 36:1115-1125.
7. Brennan J., Lu C.C., Norris D.P., Rodriguez T.A., Beddington R.S., et al. Nodal signalling in the epiblast patterns the early mouse embryo. Nature 2001, 411:965-969.
8. Bruckner K., Perez L., Clausen H., Cohen S. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 2000, 406:411-415.
9. Camus A., Perea-Gomez A., Moreau A., Collignon J. Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo. Dev. Biol. 2006, 295:743-755.
10. Chen Y., Abraham D.J., Shi-Wen X., Pearson J.D., Black C.M., et al. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol. Biol. Cell 2004, 15:5635-5646.
11. Dawson D.W., Pearce S.F., Zhong R., Silverstein R.L., Frazier W.A., et al. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 1997, 138:707-717.
12. Dyer M.A., Farrington S.M., Mohn D., Munday J.R., Baron M.H. Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 2001, 128:1717-1730.
13. Dzamba B.J., Jakab K.R., Marsden M., Schwartz M.A., DeSimone D.W. Cadherin adhesion, tissue tension, and noncanonical Wnt signaling regulate fibronectin matrix organization. Dev. Cell 2009, 16:421-432.
14. Ema M., Takahashi S., Rossant J. Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors. Blood 2006, 107:111-117.
15. Feinstein Y., Klar A. The neuronal class 2 TSR proteins F-spondin and Mindin: a small family with divergent biological activities. Int. J. Biochem. Cell Biol. 2004, 36:975-980.
16. Fiore R., Rahim B., Christoffels V.M., Moorman A.F., Puschel A.W. Inactivation of the Sema5a gene results in embryonic lethality and defective remodeling of the cranial vascular system. Mol. Cell. Biol. 2005, 25:2310-2319.
17. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007, 131:980-993.
18. Glasson S.S., Askew R., Sheppard B., Carito B.A., Blanchet T., et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 2004, 50:2547-2558.
19. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
20. Gonzalez de Peredo A., Klein D., Macek B., Hess D., Peter-Katalinic J., et al. C-mannosylation and o-fucosylation of thrombospondin type 1 repeats. Mol. Cell. Proteomics 2002, 1:11-18.
21. Gupta K., Gupta P., Wild R., Ramakrishnan S., Hebbel R.P. Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis 1999, 3:147-158.
22. Heath E., Tahri D., Andermarcher E., Schofield P., Fleming S., et al. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev. Biol. 2008, 8:18.
23. Hess D., Keusch J.J., Oberstein S.A., Hennekam R.C., Hofsteenge J. Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicron-glycosylation of thrombospondin type 1 repeats. J. Biol. Chem. 2008, 283:7354-7360.
24. Hirohata S., Wang L.W., Miyagi M., Yan L., Seldin M.F., et al. Punctin, a novel ADAMTS-like molecule, ADAMTSL-1, in extracellular matrix. J. Biol. Chem. 2002, 277:12182-12189.
25. Hofsteenge J., Huwiler K.G., Macek B., Hess D., Lawler J., et al. C-mannosylation and O-fucosylation of the thrombospondin type 1 module. J. Biol. Chem. 2001, 276:6485-6498.
26. Hogan B.L., Cooper A.R., Kurkinen M. Incorporation into Reichert's membrane of laminin-like extracellular proteins synthesized by parietal endoderm cells of the mouse embryo. Dev. Biol. 1980, 80:289-300.
27. Hogan B., Beddington B., Costantini F., Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual 1994, Cold Spring Harbor Laboratory press, New York, (373-375 pp).
28. Holbourn K.P., Acharya K.R., Perbal B. The CCN family of proteins: structure-function relationships. Trends Biochem. Sci. 2008, 33:461-473.
29. Hourcade D.E. Properdin and complement activation: a fresh perspective. Curr. Drug Targets 2008, 9:158-164.
30. Hurvitz J.R., Suwairi W.M., Van Hul W., El-Shanti H., Superti-Furga A., et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 1999, 23:94-98.
31. Iratni R., Yan Y.T., Chen C., Ding J., Zhang Y., et al. Inhibition of excess nodal signaling during mouse gastrulation by the transcriptional corepressor DRAP1. Science 2002, 298:1996-1999.
32. Iruela-Arispe M.L., Lombardo M., Krutzsch H.C., Lawler J., Roberts D.D. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 1999, 100:1423-1431.
33. Irvine A.E., Perbal B., Yeger H. Report on the fifth international workshop on the CCN family of genes. J. Cell Commun. Signal 2008, 2:95-100.
34. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003, 130:2779-2791.
35. Jimenez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 2000, 6:41-48.
36. Jones G.C., Riley G.P. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res. Ther. 2005, 7:160-169.
37. Kabrun N., Buhring H.J., Choi K., Ullrich A., Risau W., et al. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 1997, 124:2039-2048.
38. Klar A., Baldassare M., Jessell T.M. F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cell 1992, 69:95-110.
39. Kozma K., Keusch J.J., Hegemann B., Luther K.B., Klein D., et al. Identification and characterization of abeta1, 3-glucosyltransferase that synthesizes the Glc-beta1, 3-Fuc disaccharide on thrombospondin type 1 repeats. J. Biol. Chem. 2006, 281:36742-36751.
40. Kramerova I.A., Kawaguchi N., Fessler L.I., Nelson R.E., Chen Y., et al. Papilin in development; a pericellular protein with a homology to the ADAMTS metalloproteinases. Development 2000, 127:5475-5485.
41. Kutz W.E., Gong Y., Warman M.L. WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice. Mol. Cell. Biol. 2005, 25:414-421.
42. Lawler J., Sunday M., Thibert V., Duquette M., George E.L., et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 1998, 101:982-992.
43. Le Goff C., Morice-Picard F., Dagoneau N., Wang L.W., Perrot C., et al. ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. Nat. Genet. 2008, 40:1119-1123.
44. Leask A., Abraham D.J. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 2006, 119:4803-4810.
45. Leivo I., Vaheri A., Timpl R., Wartiovaara J. Appearance and distribution of collagens and laminin in the early mouse embryo. Dev. Biol. 1980, 76:100-114.
46. Lesnik Oberstein S.A., Kriek M., White S.J., Kalf M.E., Szuhai K., et al. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Am. J. Hum. Genet. 2006, 79:562-566.
47. Luo Y., Koles K., Vorndam W., Haltiwanger R.S., Panin V.M. Protein O-fucosyltransferase 2 adds O-fucose to thrombospondin type 1 repeats. J. Biol. Chem. 2006, 281:9393-9399.
48. Luo Y., Nita-Lazar A., Haltiwanger R.S. Two distinct pathways for O-fucosylation of epidermal growth factor-like or thrombospondin type 1 repeats. J. Biol. Chem. 2006, 281:9385-9392.
49. Luque A., Carpizo D.R., Iruela-Arispe M.L. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J. Biol. Chem. 2003, 278:23656-23665.
50. Luther K.B., Haltiwanger R.S. Role of unusual O-glycans in intercellular signaling. Int. J. Biochem. Cell Biol. 2009, 41:1011-1024.
51. Majumdar M.K., Askew R., Schelling S., Stedman N., Blanchet T., et al. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum. 2007, 56:3670-3674.
52. Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., et al. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA 2003, 100:3299-3304.
53. Meiniel A., Meiniel R., Goncalves-Mendes N., Creveaux I., Didier R., et al. The thrombospondin type 1 repeat (TSR) and neuronal differentiation: roles of SCO-spondin oligopeptides on neuronal cell types and cell lines. Int. Rev. Cytol. 2003, 230:1-39.
54. Mitchell K.J., Pinson K.I., Kelly O.G., Brennan J., Zupicich J., et al. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 2001, 28:241-249.
55. Mo F.E., Muntean A.G., Chen C.C., Stolz D.B., Watkins S.C., et al. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol. Cell. Biol. 2002, 22:8709-8720.
56. Moloney D.J., Shair L.H., Lu F.M., Xia J., Locke R., et al. Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J. Biol. Chem. 2000, 275:9604-9611.
57. Moloney D.J., Panin V.M., Johnston S.H., Chen J., Shao L., et al. Fringe is a glycosyltransferase that modifies Notch. Nature 2000, 406:369-375.
58. Motoike T., Markham D.W., Rossant J., Sato T.N. Evidence for novel fate of Flk1+ progenitor: contribution to muscle lineage. Genesis 2003, 35:153-159.
59. Nagy A., Gertsenstein M., Vintersten K., Behringer R.R. Manipulating the Mouse Embryo: A Laboratory Manual 2003, Cold Spring Harbor Laboratory Press, (31-141 pp).
60. Nakamura Y., Weidinger G., Liang J.O., Aquilina-Beck A., Tamai K., et al. The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. J. Clin. Invest. 2007, 117:3075-3086.
61. Nakazawa F., Nagai H., Shin M., Sheng G. Negative regulation of primitive hematopoiesis by the FGF signaling pathway. Blood 2006, 108:3335-3343.
62. O'Brien B.R. Development of haemoglobin by de-embryonated chick blastoderms cultured in vitro and the effect of abnormal RNA upon its synthesis. J. Embryol. Exp. Morphol. 1961, 9:202-221.
63. Okajima T., Irvine K.D. Regulation of notch signaling by o-linked fucose. Cell 2002, 111:893-904.
64. Okajima T., Xu A., Irvine K.D. Modulation of notch-ligand binding by protein O-fucosyltransferase 1 and fringe. J. Biol. Chem. 2003, 278:42340-42345.
65. Porter S., Clark I.M., Kevorkian L., Edwards D.R. The ADAMTS metalloproteinases. Biochem. J. 2005, 386:15-27.
66. Rampal R., Arboleda-Velasquez J.F., Nita-Lazar A., Kosik K.S., Haltiwanger R.S. Highly conserved O-fucose sites have distinct effects on Notch1 function. J. Biol. Chem. 2005, 280:32133-32140.
67. Ricketts L.M., Dlugosz M., Luther K.B., Haltiwanger R.S., Majerus E.M. O-fucosylation is required for ADAMTS13 secretion. J. Biol. Chem. 2007, 282:17014-17023.
68. Rodriguez-Manzaneque J.C., Lane T.F., Ortega M.A., Hynes R.O., Lawler J., et al. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 2001, 98:12485-12490.
69. Rozario T., Desimone D.W. The extracellular matrix in development and morphogenesis: a dynamic view. Dev. Biol. 2010, 341:126-140.
70. Sasamura T., Sasaki N., Miyashita F., Nakao S., Ishikawa H.O., et al. neurotic, a novel maternal neurogenic gene, encodes an O-fucosyltransferase that is essential for Notch-Delta interactions. Development 2003, 130:4785-4795.
71. Sato T., Sato M., Kiyohara K., Sogabe M., Shikanai T., et al. Molecular cloning and characterization of a novel human beta1, 3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domain. Glycobiology 2006, 16:1194-1206.
72. Schubert D., Klar A., Park M., Dargusch R., Fischer W.H. F-spondin promotes nerve precursor differentiation. J. Neurochem. 2006, 96:444-453.
73. Shi S., Stanley P. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc. Natl. Acad. Sci. USA 2003, 100:5234-5239.
74. Shiratsuchi T., Nishimori H., Ichise H., Nakamura Y., Tokino T. Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1). Cytogenet. Cell Genet. 1997, 79:103-108.
75. Shukla S., Nair R., Rolle M.W., Braun K.R., Chan C.K., et al. Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation. J. Histochem. Cytochem. 2010, 58:345-358.
76. Shumacher A., Faust C., Magnuson T. Positional cloning of a global regulator of anterior-posterior patterning in mice. Nature 1996, 383:250-253.
77. Stahl M., Uemura K., Ge C., Shi S., Tashima Y., et al. Roles of Pofut1 and O-fucose in mammalian Notch signaling. J. Biol. Chem. 2008, 283:13638-13651.
78. Suga A., Hikasa H., Taira M. Xenopus ADAMTS1 negatively modulates FGF signaling independent of its metalloprotease activity. Dev. Biol. 2006, 295:26-39.
79. Tan K., Duquette M., Liu J.H., Dong Y., Zhang R., et al. Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication. J. Cell Biol. 2002, 159:373-382.
80. Tortorella M., Pratta M., Liu R.Q., Abbaszade I., Ross H., et al. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J. Biol. Chem. 2000, 275:25791-25797.
81. Tremblay K.D., Dunn N.R., Robertson E.J. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 2001, 128:3609-3621.
82. Tucker R.P. The thrombospondin type 1 repeat superfamily. Int. J. Biochem. Cell Biol. 2004, 36:969-974.
83. Tzarfaty-Majar V., Lopez-Alemany R., Feinstein Y., Gombau L., Goldshmidt O., et al. Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix. J. Biol. Chem. 2001, 276:28233-28241.
84. Vazquez F., Hastings G., Ortega M.A., Lane T.F., Oikemus S., et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem. 1999, 274:23349-23357.
85. Volpert O.V., Zaichuk T., Zhou W., Reiher F., Ferguson T.A., et al. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med. 2002, 8:349-357.
86. Wang Y., Lee G.F., Kelley R.F., Spellman M.W. Identification of a GDP-l-fucose:polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains. Glycobiology 1996, 6:837-842.
87. Wang Y., Shao L., Shi S., Harris R.J., Spellman M.W., et al. Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase. J. Biol. Chem. 2001, 276:40338-40345.
88. Wang L.W., Dlugosz M., Somerville R.P., Raed M., Haltiwanger R.S., et al. O-fucosylation of thrombospondin type 1 repeats in ADAMTS-like-1/punctin-1 regulates secretion: implications for the ADAMTS superfamily. J. Biol. Chem. 2007, 282:17024-17031.
89. Wang L.W., Leonhard-Melief C., Haltiwanger R.S., Apte S.S. Post-translational modification of thrombospondin type-1 repeats in ADAMTS-like 1/punctin-1 by C-mannosylation of tryptophan. J. Biol. Chem. 2009, 284:30004-30015.
90. Wartiovaara J., Leivo I., Vaheri A. Expression of the cell surface-associated glycoprotein, fibronectin, in the early mouse embryo. Dev. Biol. 1979, 69:247-257.
91. Wiggins C.A., Munro S. Activity of the yeast MNN1 alpha-1, 3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. Proc. Natl. Acad. Sci. USA 1998, 95:7945-7950.
92. Xu X., Dong C., Vogel B.E. Hemicentins assemble on diverse epithelia in the mouse. J. Histochem. Cytochem. 2007, 55:119-126.
93. Yamaguchi T.P., Dumont D.J., Conlon R.A., Breitman M.L., Rossant J. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 1993, 118:489-498.
94. Yang Z., Strickland D.K., Bornstein P. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J. Biol. Chem. 2001, 276:8403-8408.
95. Zhang X., Lawler J. Thrombospondin-based antiangiogenic therapy. Microvasc. Res. 2007, 74:90-99.